{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T03:33:56Z","timestamp":1758944036351},"reference-count":17,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2012,7]]},"DOI":"10.1097\/mph.0b013e318238818f","type":"journal-article","created":{"date-parts":[[2013,6,13]],"date-time":"2013-06-13T21:27:59Z","timestamp":1371158879000},"page":"402-405","source":"Crossref","is-referenced-by-count":2,"title":["Quantitative RT-PCR Analysis of the MOZ-CBP Fusion Transcript in Therapy-related Acute Myeloid Leukemia With t(8;16)(p11;p13)"],"prefix":"10.1097","volume":"34","author":[{"given":"Atsushi","family":"Fujiki","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toshihiko","family":"Imamura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akiyo","family":"Furutani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Waka","family":"Hatano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daisuke","family":"Asai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshifumi","family":"Hirashima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mitsuru","family":"Miyachi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shinichi","family":"Tamura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kunihiko","family":"Tsuchiya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomoko","family":"Iehara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroyuki","family":"Ishida","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takao","family":"Yoshihara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hajime","family":"Hosoi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-19-20210227","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1038\/leu.2008.388","article-title":"AML with translocation t(8;16)(p11;p13) demonstrates unique cytomorphological, cytogenetic, molecular and prognostic features.","volume":"23","author":"Haferlach","year":"2009","journal-title":"Leukemia"},{"key":"R2-19-20210227","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1038\/leu.2008.128","article-title":"Acute myeloid leukaemia with 8p11 (MYST3) rearrangement: an integrated cytologic, cytogenetic and molecular study by the groupe francophone de cytogenetique hematologique.","volume":"22","author":"Gervais","year":"2008","journal-title":"Leukemia"},{"key":"R3-19-20210227","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1002\/1098-2264(200008)28:4<415::AID-GCC7>3.0.CO;2-I","article-title":"RT-PCR analysis of the MOZ-CBP and CBP-MOZ chimeric transcripts in acute myeloid leukemias with t(8;16)(p11;p13).","volume":"28","author":"Panagopoulos","year":"2000","journal-title":"Genes Chromosomes Cancer"},{"key":"R4-19-20210227","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1002\/gcc.10137","article-title":"Genomic characterization of MOZCBP and CBPMOZ chimeras in acute myeloid leukemia suggests the involvement of a damage-repair mechanism in the origin of the t(8;16)(p11;p13).","volume":"36","author":"Panagopoulos","year":"2003","journal-title":"Genes Chromosomes Cancer"},{"key":"R5-19-20210227","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1038\/sj.leu.2403353","article-title":"RT-PCR and FISH analysis of acute myeloid leukemia with t(8;16)(p11;p13) and chimeric MOZ and CBP transcripts: breakpoint cluster region and clinical implications.","volume":"18","author":"Schmidt","year":"2004","journal-title":"Leukemia"},{"key":"R6-19-20210227","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1038\/sj.leu.2404015","article-title":"Prognostic value of minimal residual disease (MRD) in acute myeloid leukemia (AML) with favorable cytogenetics t(8;21) and inv(16).","volume":"20","author":"Perea","year":"2006","journal-title":"Leukemia"},{"key":"R7-19-20210227","doi-asserted-by":"crossref","first-page":"3206","DOI":"10.1182\/blood-2009-10-248146","article-title":"Molecular response to treatment redefines all prognostic factors in children and adolescents with B-cell precursor acute lymphoblastic leukemia: results in 3184 patients of the AIEOP-BFM ALL 2000 study.","volume":"115","author":"Conter","year":"2010","journal-title":"Blood"},{"key":"R8-19-20210227","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1002\/cncr.23128","article-title":"Monitoring of minimal residual disease in acute myeloid leukemia.","volume":"112","author":"Kern","year":"2008","journal-title":"Cancer"},{"key":"R9-19-20210227","first-page":"526","article-title":"Real-time PCR array for simultaneous detection of 37 kinds of fusion genes in leukemia.","volume":"87","author":"Liu","year":"2007","journal-title":"Zhonghua Yi Xue Za Zhi"},{"key":"R10-19-20210227","doi-asserted-by":"crossref","first-page":"4007","DOI":"10.1200\/JCO.2008.18.7948","article-title":"Risk-stratified therapy and the intensive use of cytarabine improves the outcome in childhood acute myeloid leukemia: the AML99 trial from the Japanese Childhood AML Cooperative Study Group.","volume":"27","author":"Tsukimoto","year":"2009","journal-title":"J Clin Oncol"},{"key":"R11-19-20210227","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1038\/sj.leu.2404535","article-title":"Optimization of PCR-based minimal residual disease diagnostics for childhood acute lymphoblastic leukemia in a multi-center setting.","volume":"21","author":"van der Velden","year":"2007","journal-title":"Leukemia"},{"key":"R12-19-20210227","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.critrevonc.2004.06.004","article-title":"Monitoring of minimal residual disease in acute myeloid leukemia.","volume":"56","author":"Kern","year":"2005","journal-title":"Crit Rev Oncol Hematol"},{"key":"R13-19-20210227","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1111\/j.1365-2141.2008.07488.x","article-title":"Monitoring minimal residual disease in acute myeloid leukaemia with NPM1 mutations by quantitative PCR: clonal evolution is a limiting factor.","volume":"144","author":"Papadaki","year":"2009","journal-title":"Br J Haematol"},{"key":"R14-19-20210227","doi-asserted-by":"crossref","first-page":"1472","DOI":"10.1038\/leu.2009.51","article-title":"Standardization of WT1 mRNA quantitation for minimal residual disease monitoring in childhood AML and implications of WT1 gene mutations: a European multicenter study.","volume":"23","author":"Willasch","year":"2009","journal-title":"Leukemia"},{"key":"R15-19-20210227","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.leukres.2005.08.030","article-title":"Minimal residual core binding factor AMLs by real time quantitative PCRinitial response to chemotherapy predicts event free survival and close monitoring of peripheral blood unravels the kinetics of relapse.","volume":"30","author":"Stentoft","year":"2006","journal-title":"Leuk Res"},{"key":"R16-19-20210227","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/S1470-2045(10)70090-5","article-title":"Minimal residual disease-directed therapy for childhood acute myeloid leukemia: results of the AML02 multicenter trial.","volume":"11","author":"Rubinitz","year":"2010","journal-title":"Lancet Oncol"},{"key":"R17-19-20210227","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1200\/JCO.2008.17.6065","article-title":"Prognostic value of minimal residual disease quantification before allogeneic stem-cell transplantation in relapsed childhood acute lymphoblastic leukemia: the ALL-REZ BFM Study Group.","volume":"27","author":"Bader","year":"2009","journal-title":"J Clin Oncol"}],"container-title":["Journal of Pediatric Hematology\/Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MPH.0b013e318238818f","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T04:11:45Z","timestamp":1620965505000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00043426-201207000-00019"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,7]]},"references-count":17,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2012]]}},"URL":"https:\/\/doi.org\/10.1097\/mph.0b013e318238818f","relation":{},"ISSN":["1077-4114"],"issn-type":[{"value":"1077-4114","type":"print"}],"subject":[],"published":{"date-parts":[[2012,7]]}}}